Microwave ablation followed by immediate biopsy in the treatment of non-small cell lung cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–1205.
   PubMed Web of Science ®Google Scholar
• Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 2010;211:68–72.
   PubMed Web of Science ®Google Scholar
• Powell JW, Dexter E, Scalzetti EM, et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009;10:885–894.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621–628.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Huang G, et al. Repeated percutaneous microwave ablation for local recurrence of inoperable Stage I nonsmall cell lung cancer. J Can Res Therapy. 2017;13:683–688.
   PubMed Web of Science ®Google Scholar
• Han X, Yang X, Ye X, et al. Computed tomography-guided percutaneous microwave ablation of patients 75 years of age and older with early-stage nonsmall cell lung cancer. Indian J Cancer. 2015;52:56–60.
   PubMed Web of Science ®Google Scholar
• Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol. 2017;34:96.
   PubMed Web of Science ®Google Scholar
• Nour-Eldin NA, Exner S, Al-Subhi M, et al. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA). Int J Hyperthermia. 2017;33:1–9.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ye X, Yang X, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2015;38:135–142.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ye X, Yang X, et al. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol. 2015;32:464.
   PubMed Web of Science ®Google Scholar
• Zhong L, Sun S, Shi J, et al. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis. 2017;9:590–597.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Kondo C, Sato Y, et al. Diagnostic ability of percutaneous needle biopsy immediately after radiofrequency ablation for malignant lung tumors: an initial experience. Cardiovasc Intervent Radiol. 2016;39:1187–1192.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Kondo C, Sato Y, et al. Pathologic diagnosis and genetic analysis of a lung tumor needle biopsy specimen obtained immediately after radiofrequency ablation. Cardiovasc Intervent Radiol. 2018;41:594–602.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: Biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280:949–959.
   PubMed Web of Science ®Google Scholar
• Snoeren N, Huiskens J, Rijken AM, et al. Viable tumor tissue adherent to needle applicators after local ablation: a riskfactor for local tumor progression. Ann Surg Oncol. 2011;18:1527–1510.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Garg SK, Cohen P, et al. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation. Ann Surg Oncol. 2013;20:676–683.
   Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Ye X, Fan W, Wang H, et al. Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J Cancer Res Ther. 2018;14:730–744.
   PubMed Web of Science ®Google Scholar
• Steinke K, Habicht JM, Thomsen S, et al. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol. 2002;25:543–546.
   PubMed Web of Science ®Google Scholar
• Scott WJ, Young N, Goldberg M, et al. Tumor cell viability following radiofrequency ablation of resectable primary lung cancer: initial results from an ablate and resect study. Lung Cancer. 2003;41:S135.
   Google Scholar
• Nguyen CL, Scott WJ, Young NA, et al. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005;128:3507–3511.
   PubMed Web of Science ®Google Scholar
• Ambrogi MC, Fontanini G, Cioni R, et al. Biologic effects of radiofrequency thermal ablation on non–small cell lung cancer: Results of a pilot study. J Thorac Cardiovasc Surg. 2006;131:1002–1006.
   PubMed Web of Science ®Google Scholar
• Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer—a preliminary report of 33 patients. AJR. 2004;183:1003–1011.
   PubMed Web of Science ®Google Scholar
• Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850–857.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–763.
   PubMed Web of Science ®Google Scholar